Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Biochem Biophys Res Commun ; 441(2): 286-90, 2013 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-24036266

RESUMO

In order to obtain compounds with modified 2-APB activities, we synthesized number of 2-APB analogues and analyzed their inhibitory activities for SOCE. The IC50 of 2-APB for SOCE inhibition is 3 µM while IC50 of some of our 2-APB analogues range 0.1-10 µM. The adducts of amino acids with diphenyl borinic acid have strong inhibitory activities. By using these compounds, we will be able to regulate intracellular Ca(2+) concentration and consequent cellular processes more efficiently than with 2-APB.


Assuntos
Compostos de Boro/química , Compostos de Boro/farmacologia , Sinalização do Cálcio/efeitos dos fármacos , Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/metabolismo , Animais , Células CHO , Cricetulus , Cardiopatias/tratamento farmacológico , Cardiopatias/metabolismo
2.
Chembiochem ; 14(1): 115-22, 2013 Jan 02.
Artigo em Inglês | MEDLINE | ID: mdl-23239555

RESUMO

Ras proteins are of importance in cell proliferation, and hence their mutated forms play causative roles in many kinds of cancer in different tissues. Inhibition of the Ras-depalmitoylating enzyme acyl protein thioesterases APT1 and -2 is a new approach to modulating the Ras cycle. Here we present boronic and borinic acid derivatives as a new class of potent and nontoxic APT inhibitors. These compounds were detected by extensive library screening using chemical arrays and turned out to inhibit human APT1 and -2 in a competitive mode. Furthermore, one of the molecules was demonstrated to inhibit Erk1/2 phosphorylation significantly.


Assuntos
Boro/química , Boro/farmacologia , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Tioléster Hidrolases/antagonistas & inibidores , Animais , Boro/toxicidade , Cães , Avaliação Pré-Clínica de Medicamentos , Inibidores Enzimáticos/toxicidade , Humanos , Lipoilação/efeitos dos fármacos , Células Madin Darby de Rim Canino , Proteínas ras/antagonistas & inibidores , Proteínas ras/metabolismo
3.
Biochem Biophys Res Commun ; 416(1-2): 13-7, 2011 Dec 09.
Artigo em Inglês | MEDLINE | ID: mdl-22056561

RESUMO

Huntington's disease (HD) is a dominantly inherited neurodegenerative disease caused by an expansion of the polyglutamine (polyQ) stretch in huntingtin (htt). Previously, it has been shown that inhibition of the inositol 1,4,5-trisphosphate receptor type 1 (IP3R1) activity reduced aggregation of pathogenic polyQ proteins. Experimentally, this effect was achieved by modification of the intracellular IP3 levels or by application of IP3R1 inhibitors, such as 2-aminoethyl diphenylborinate (2-APB). Unfortunately, there are certain concerns about the 2-APB specificity and cytotoxicity. Moreover, a direct link between IP3R1 and polyQ aggregation has not been shown yet. In this study we show, that down-regulation of the IP3R1 levels by shRNA reduced the aggregation of mutant htt. We tested 2-APB analogs in an attempt to identify less toxic and more IP3R1-specific compounds and found that the effect of these analogs on the reduction of the mutant htt aggregation did weakly correlate with their inhibitory action toward the IP3-induced Ca(2+) release (IICR). Their effect on aggregation was not correlated with the store-operated Ca(2+) entry (SOCE), which is another target of the 2-APB related compounds. Our findings suggest that besides functional contribution of the IP3R inhibition on the mutant htt aggregation there are additional mechanisms for the anti-aggregation effect of the 2-APB related compounds.


Assuntos
Compostos de Boro/química , Compostos de Boro/farmacologia , Receptores de Inositol 1,4,5-Trifosfato/antagonistas & inibidores , Receptores de Inositol 1,4,5-Trifosfato/genética , Proteínas do Tecido Nervoso/metabolismo , Proteínas Nucleares/metabolismo , Peptídeos/metabolismo , Animais , Linhagem Celular Tumoral , Avaliação Pré-Clínica de Medicamentos , Técnicas de Silenciamento de Genes , Proteína Huntingtina , Masculino , Camundongos , Mutação , Proteínas do Tecido Nervoso/genética , Proteínas Nucleares/genética , RNA Interferente Pequeno/genética , Bibliotecas de Moléculas Pequenas
4.
Bioorg Med Chem Lett ; 21(1): 377-9, 2011 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-21134746

RESUMO

Potent transglutaminase inhibitors were obtained from disulfide compounds, cystamine, dimethyl cystine, and dimethyl homocystine. The disulfide bond and thiophene ring play an important role in inhibitory activity of synthesized aryl ß-amino ketones.


Assuntos
Inibidores Enzimáticos/química , Cetonas/química , Transglutaminases/antagonistas & inibidores , Dissulfetos/química , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/farmacologia , Cetonas/síntese química , Cetonas/farmacologia , Relação Estrutura-Atividade , Tiofenos/química , Transglutaminases/metabolismo
5.
Bioorg Med Chem Lett ; 20(4): 1395-8, 2010 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-20097561

RESUMO

Store-operated calcium entry (SOCE) is an important mechanism for replenishing intracellular calcium stores and for sustaining calcium signaling. We developed a method for synthesis of bisboron compounds that have two borinic acids or their esters in one molecule. These compounds are analogues of 2-APB, which is widely used as a membrane-permeable SOCE inhibitor. Further, we examined the effect of the newly synthesized bisboron compounds on SOCE in Jurkat T cells. All the bisboron compounds showed strong inhibitory activity on SOCE, with IC50 values of less than 1 microM, which were 20-45 times lower than observed with 2-APB.


Assuntos
Ácidos Borínicos/síntese química , Compostos de Boro/síntese química , Cálcio/antagonistas & inibidores , Cálcio/metabolismo , Ácidos Borínicos/química , Ácidos Borínicos/farmacologia , Compostos de Boro/química , Compostos de Boro/farmacologia , Canais de Cálcio , Humanos , Concentração Inibidora 50 , Células Jurkat , Estrutura Molecular , Transdução de Sinais/efeitos dos fármacos
6.
Bioorg Med Chem Lett ; 20(3): 1141-4, 2010 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-20053561

RESUMO

Aryl beta-aminoethyl ketones were discovered as potent inhibitors of tissue transglutaminase. Heteroaryl-like thiophene groups and N-benzyl N-t-butyl aminoethyl group are critical to the strong inhibitory activity of aryl beta-aminoethyl ketones.


Assuntos
Cetonas/química , Transglutaminases/antagonistas & inibidores , Animais , Cobaias , Cetonas/metabolismo , Cetonas/farmacologia , Fígado/efeitos dos fármacos , Fígado/enzimologia , Transglutaminases/metabolismo
7.
Cell Calcium ; 38(2): 59-72, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16099504

RESUMO

Intracellular calcium [Ca(2+)](i) is mobilized in many cell types in response to activation of phosphoinositide (PIP(n)) signaling pathways involving PtdIns(4,5)P(2) or PtdIns(3,4,5)P(3). To further explore the relationship between increases in intracellular PIP(n) concentrations and mobilization of [Ca(2+)](i), each of the seven phosphorylated phosphoinositides (PIP(n)s) were delivered into cells and the metabolism and physiological effects of the exogenously administered PIP(n)s were determined. The efficient cellular delivery of fluorophore-tagged and native PIP(n)s was accomplished using histone protein, neomycin, and dendrimeric polyamines. PtdIns(4,5)P(2) fluorophore-tagged analogs with short- and long-acyl chains were substrates for cellular enzymes in vitro and for phospholipases in stimulated fibroblasts. PtdIns(4)P, PtdIns(3,4)P(2) and PtdIns(4,5)P(2), each induced calcium mobilization rapidly after exogenous addition to fibroblasts. PtdIns(3,4,5)P(3) induced a significant, but smaller increase in intracellular calcium. These observations suggest that PIP(n)s other than PtdIns(4,5)P(2) or PtdIns(3,4,5)P(3) may have direct roles in signaling involving [Ca(2+)](i).


Assuntos
Sinalização do Cálcio/fisiologia , Cálcio/metabolismo , Líquido Intracelular/metabolismo , Fosfatidilinositóis/metabolismo , Transdução de Sinais/fisiologia , Animais , Sinalização do Cálcio/efeitos dos fármacos , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Corantes Fluorescentes , Histonas/metabolismo , Histonas/farmacologia , Substâncias Macromoleculares/metabolismo , Substâncias Macromoleculares/farmacologia , Camundongos , Células NIH 3T3 , Fosfatidilinositóis/química , Fosfatidilinositóis/farmacologia , Fosforilação , Estrutura Terciária de Proteína/fisiologia , Transdução de Sinais/efeitos dos fármacos
8.
Cell Calcium ; 33(1): 19-26, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12526884

RESUMO

The localization and function of Ca(2+) stores in isolated chromaffin cells of rat adrenal medulla were investigated using confocal laser microscopy and amperometry. Binding sites for BODIPY-inositol 1,4,5-trisphosphate (IP(3)), -ryanodine (Ry), and -thapsigargin (Thap) were both perinuclear and at the cell periphery. The endoplasmic reticulum (ER), which was identified by ER Tracker dye, took up fluorescent Ry and IP(3), and the majority of BODIPY-Ry-binding area was bound by fluorescent IP(3). Under Ca(2+)-free conditions, the amount of caffeine-induced catecholamine secretion was 33% of that of muscarine-induced secretion, but muscarine induced little or no secretion after exposure to caffeine. Muscarine-induced Ca(2+) increases, as observed with fluo-3, lasted for a few tens of seconds under Ca(2+)-free conditions, whereas a caffeine-induced Ca(2+) transient diminished rapidly with a half decay time of 3s and this spike-like Ca(2+) transient was then followed by a sustained increase with a low level. These results indicate that IP(3) receptors and Ry receptors (RyRs) are present in common ER Ca(2+) storage and the lower potency of caffeine for secretion may be due to a rapid decrease in RyR channel activity to a low level.


Assuntos
Medula Suprarrenal/metabolismo , Sinalização do Cálcio/fisiologia , Cálcio/metabolismo , Células Cromafins/metabolismo , Medula Suprarrenal/citologia , Medula Suprarrenal/efeitos dos fármacos , Animais , Sítios de Ligação/efeitos dos fármacos , Sítios de Ligação/fisiologia , Cafeína/farmacologia , Canais de Cálcio/metabolismo , Sinalização do Cálcio/efeitos dos fármacos , Catecolaminas/metabolismo , Células Cultivadas , Células Cromafins/citologia , Células Cromafins/efeitos dos fármacos , Relação Dose-Resposta a Droga , Retículo Endoplasmático/efeitos dos fármacos , Retículo Endoplasmático/metabolismo , Corantes Fluorescentes , Receptores de Inositol 1,4,5-Trifosfato , Muscarina/farmacologia , Ratos , Tempo de Reação/efeitos dos fármacos , Tempo de Reação/fisiologia , Receptores Citoplasmáticos e Nucleares/metabolismo , Canal de Liberação de Cálcio do Receptor de Rianodina/metabolismo
9.
Cell Calcium ; 47(1): 1-10, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19945161

RESUMO

Store-operated calcium entry (SOCE) or calcium release-activated calcium current (I(CRAC)) is a critical pathway to replenish intracellular calcium stores, and plays indispensable roles in cellular functions such as antigen-induced T lymphocyte activation. Despite the importance of I(CRAC) in cellular functions, lack of potent and specific inhibitor has limited the approaches to the function of I(CRAC) in native cells. 2-Aminoethyl diphenylborinate (2-APB) is a widely used SOCE/I(CRAC) inhibitor, while its effect is rather unspecific. In the attempt to develop more potent and selective compounds here we identified two structurally isomeric 2-APB analogues that are 100-fold more potent than 2-APB itself. One of the 2-APB analogues activates and inhibits endogenous SOCE depending on the concentration while the other only inhibits it. The 2-APB analogue inhibits store depletion-mediated STIM1 clustering as well as heterologously expressed CRAC current. Together with the observation that, unlike 2-APB, the analogue compounds failed to activate CRACM3/Orai3 current in the absence of STIM, our results suggest that inhibition and activation of SOCE/I(CRAC) by the 2-APB analogues is mediated by STIM.


Assuntos
Compostos de Boro/farmacologia , Sinalização do Cálcio/efeitos dos fármacos , Ativação do Canal Iônico/efeitos dos fármacos , Proteínas de Membrana/metabolismo , Proteínas de Neoplasias/metabolismo , Canais de Cátion TRPC/metabolismo , Animais , Compostos de Boro/química , Células CHO , Canais de Cálcio/metabolismo , Sinalização do Cálcio/fisiologia , Galinhas , Cricetinae , Cricetulus , Células HeLa , Humanos , Ativação do Canal Iônico/fisiologia , Células Jurkat , Masculino , Proteínas de Membrana/genética , Camundongos , Proteínas de Neoplasias/genética , Técnicas de Patch-Clamp , Molécula 1 de Interação Estromal
11.
Biochem Biophys Res Commun ; 352(2): 277-82, 2007 Jan 12.
Artigo em Inglês | MEDLINE | ID: mdl-17140548

RESUMO

Capacitative calcium entry (CCE), the mechanism that replenishes the internal Ca2+ stores with Ca2+ from the extracellular milieu in response to depletion of the store, is mediated by Ca2+ channels in the plasma membrane generally referred to as store-operated channels (SOCs). However, the roles of SOCs in the more physiological context have been fully elucidated. 2-Aminoethyl diphenylborinate (2-APB) strongly inhibits SOCs, as well as inositol-1,4,5 trisphosphate (IP3) receptors. In the present study, we screened a library of 166 2-APB analogues for effects on CCE and IP3-induced Ca2+ release in order to discover specific SOC inhibitors, and found that some blocked both store-operated and receptor-operated Ca2+ influx more strongly and selectively than 2-APB. Indeed, these new compounds ceased the prolonged intracellular Ca2+ oscillations induced by a low concentration of ATP in CHO-K1 cells. These novel SOC inhibitors will be valuable pharmacological and biochemical tools for elucidating the physiological roles.


Assuntos
Compostos de Boro/administração & dosagem , Canais de Cálcio/efeitos dos fármacos , Cálcio/metabolismo , Membrana Celular/metabolismo , Ativação do Canal Iônico/fisiologia , Animais , Células CHO , Canais de Cálcio/fisiologia , Membrana Celular/efeitos dos fármacos , Cricetinae , Cricetulus , Ativação do Canal Iônico/efeitos dos fármacos , Taxa de Depuração Metabólica/efeitos dos fármacos
12.
J Physiol ; 564(Pt 1): 161-72, 2005 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-15695243

RESUMO

Adrenal medullary (AM) cells are exposed to high concentrations of cortical hormones, one of which is a ouabain-like substance. Thus, the effects of ouabain on catecholamine secretion and distribution of Na+,K+-ATPase alpha and beta subunits in rat and guinea-pig AM cells were examined using amperometry and immunological techniques. While exposure to 1 microm ouabain did not have a marked effect on resting secretion, it induced an increase in secretion due to mobilization of Ca2+ ions that were stored during a 4 min interval between muscarine applications. Immunocytochemistry revealed that Na+,K+-ATPase alpha1 subunit-like and beta3 subunit-like immunoreactive (IR) materials were distributed ubiquitously at the cell periphery, whereas alpha2- and beta2-like IR materials were present in restricted parts of the cell periphery. The alpha1 and alpha2 subunits were mainly immunoprecipitated from AM preparations by anti-beta3 and anti-beta2 antisera, respectively. Peripheral BODIPY-FL-InsP3 binding sites were localized below membrane domains with alpha2- and beta2-like IR materials. The results indicate that in AM cells, alpha1beta3 isozymes of Na+,K+-ATPase were present ubiquitously in the plasma membrane, while alpha2beta2 isozymes were in the membrane domain closely associated with peripheral Ca2+ store sites. This close association of the alpha2beta2 isozyme with peripheral Ca2+ store sites may account for the facilitation of mobilization-dependent secretion in the presence of 1 microm ouabain.


Assuntos
Medula Suprarrenal/enzimologia , Células Cromafins/enzimologia , Subunidades Proteicas/química , Subunidades Proteicas/fisiologia , ATPase Trocadora de Sódio-Potássio/química , ATPase Trocadora de Sódio-Potássio/fisiologia , Medula Suprarrenal/efeitos dos fármacos , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/enzimologia , Células Cromafins/efeitos dos fármacos , Cobaias , Isoenzimas/química , Isoenzimas/fisiologia , Ouabaína/farmacologia , Ratos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa